EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A simplified amoxicillin regimen with dose frequency based on post-natal age in neonates with confirmed or suspected infection

Mispah Mukap, Corin Sprod, Okhee Yoo, Nakapi Tefuarani, John Vince, Moses Laman, Madhu Page-Sharp, Brioni R Moore, Kevin T Batty iD, Timothy M E Davis iD, Sam Salman iD, Laurens Manning iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01491-24 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Mispah Mukap und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Papua New Guinea, Port Moresby, Papua New Guinea. Hauptthemen laut MEDLINE: Amoxicillin, Anti-Bacterial Agents, Sepsis. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DHAC | National Health and Medical Research Council (NHMRC), Medical Research Future Fund, Stan Perron Charitable Foundation (Stan Perron Charitable Trust).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amoxicillin plus gentamicin is the recommended first-line empiric therapy for neonates with infection. Guidelines vary widely in dose (mg/kg), dose frequency, and adjustments according to post-menstrual age (PMA) and post-natal age (PNA). We aimed to develop a population pharmacokinetic (PK) model for amoxicillin in neonates with clinical evidence of sepsis and design optimal dosing regimens. One hundred seventy-seven neonates receiving intravenous amoxicillin for infection were enrolled in a prospective, observational PK study in Papua New Guinea (PNG). The probability of PK-pharmacodynamic target attainment (PK-PD PTA) was determined based on minimum inhibitory concentrations (MIC) and the proportion of time concentrations that remained above these values (%T > MIC). Neonates with concentrations > 140 mg/L were considered to be at increased risk of amoxicillin neurotoxicity. A population PK model was developed. Simulations tested existing guidelines and proposed simplified regimens. The median PMA and PNA were 38 (37–40) weeks and 0 (0–2) days, respectively. From simulations, existing regimens with 50 or 100 mg/kg doses were associated with higher potential neurotoxic concentrations (24.9% and 84.5%, respectively). With the existing 30 mg/kg PNG regimen, neonates receiving twice-daily dosing between 3 and 7 days were systematically underdosed. A proposed 30 mg/kg regimen, with twice-daily dosing for the first 2 days PNA and three times daily from day 3, provides an optimal balance between the probability of PK-PD target attainment while minimizing toxicity. For fixed volume dosing, using 52 mg (0.25 mL of 250 mg in 1.2 mL) for those

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmoxicillinAnti-Bacterial AgentsSepsisHumansInfant, NewbornMicrobial Sensitivity TestsFemaleProspective StudiesMaleGentamicinsPapua New Guinea

Stichwörter der Autor:innen

amoxicillinampicillininfectionneonatespharmacokineticsepsis

Substanzen

AmoxicillinAnti-Bacterial AgentsGentamicins

Autor:innen und Institutionen

  • School of Medicine, University of Papua New Guinea, Port Moresby, Papua New Guinea.
  • Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
  • Pharmacy, School of Allied Health, University of Western Australia, Nedlands, Australia.
  • Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
  • Medical School, University of Western Australia, Harry Perkins Research Institute, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
  • Department of Medicine, Fremantle Hospital, Fremantle, Western Australia, Australia.

ORCID-Profile: Kevin T Batty, Timothy M E Davis, Sam Salman, Laurens Manning

Förderung

  • DHAC | National Health and Medical Research Council (NHMRC)
  • Medical Research Future Fund
  • Stan Perron Charitable Foundation (Stan Perron Charitable Trust)

Zitieren

APA

Mukap, M., Sprod, C., Yoo, O., Tefuarani, N., Vince, J., Laman, M., Page-Sharp, M., Moore, B. R., Batty, K. T., Davis, T. M. E., Salman, S., & Manning, L. (2025). A simplified amoxicillin regimen with dose frequency based on post-natal age in neonates with confirmed or suspected infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01491-24

Vancouver

Mukap M, Sprod C, Yoo O, Tefuarani N, Vince J, Laman M, et al. A simplified amoxicillin regimen with dose frequency based on post-natal age in neonates with confirmed or suspected infection. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01491-24

BibTeX
@article{Mukap2025,
  author = {Mukap, Mispah and Sprod, Corin and Yoo, Okhee and Tefuarani, Nakapi and Vince, John and Laman, Moses and Page-Sharp, Madhu and Moore, Brioni R and Batty, Kevin T and Davis, Timothy M E and Salman, Sam and Manning, Laurens},
  title = {A simplified amoxicillin regimen with dose frequency based on post-natal age in neonates with confirmed or suspected infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01491-24}
}
Kostenlos starten →